EVIDENCE & CONTEXT Updated: 24 September 2026
Citations & downloads
Language & reading
Text

Choose English to return to the original. Other languages use Google Translate. Original documents remain the reference.

PINNACLEAI® · THE COMPLETE STORY

Built around
the child’s life.

A life-first purpose. A documented Indian medical-device foundation. A new chapter in international readiness.

PinnacleAI® brings developmental ability measurement, readiness tracking, progress forecasting and adaptive therapy-plan support into the child’s journey—with families and professionals at its heart.

Illustration of a mother and child building with colourful blocks, connected by a flowing developmental pathway.
Illustrative family artwork · participation and growing independence.

THE PURPOSE

The outcome belongs at the beginning.

Section link

A self-sufficient, mainstream and wonderful life for the child determines the abilities, goals, methods, people, practice and review.

That means beginning with the life a child is working toward: communicating, learning, making choices, joining in, building confidence and becoming increasingly independent. A score can inform the next step; the child’s life gives that step its purpose.

Purpose

A self-sufficient, mainstream and wonderful life for the child determines the abilities, goals, people, methods, everyday practice and review.

Measure and plan

The seven-stage pathway connects capability identification and AbilityScore® measurement with readiness forecasting and a child-specific plan.

Support everyday participation

Integrated intervention, parent-guided practice, progress review and reassessment work toward growing independence and participation.

Build accountable technology

PinnacleAI® supports the pathway as licensed non-diagnostic developmental-support software with human and professional review.

THE SEVEN-STAGE PATHWAY

From capability to participation.

Section link

The pathway connects professional support with practice at home and review over time. Goals and pace remain individual to each child.

  1. Identify capabilities and measure ability

  2. Forecast readiness and create a child-specific plan

  3. Provide integrated therapies and intervention

  4. Support parent-guided everyday practice and home generalisation

  5. Track progress and correct the plan

  6. Reassess and repeat until readiness

  7. Support growing independence, school readiness and mainstream participation

Explore the full life-first philosophy

THE SOFTWARE’S ROLE

Support the people supporting the child.

Section link

The manufacturing licence names four intended functions. These support measurement, planning and review by the people involved in the child’s development.

Developmental ability measurement

Organise observations of a child’s abilities so the starting point and goals can be discussed.

Readiness tracking

Follow readiness for participation and everyday goals through repeated review.

Progress forecasting

Support planning with forecasts that are considered alongside professional judgement.

Adaptive therapy-plan support

Support review and adjustment of the child-specific plan as information changes.

People remain central. Parents, therapists, educators and caregivers are the intended users. The product is non-diagnostic; clinical and care decisions remain within appropriate human and professional review.

The BIS scope schedule names AbilityScore mapping, Prognose, Everyday Therapy through TherapeuticAI, and tracking and correction through Fusion. These names describe the documented software scope; each child’s goals and outcomes are individual.

MD-5 functions and intended users · BIS modules and scope

THE INDIAN REGULATORY FOUNDATION

A documented foundation for the next chapter.

Section link

Each document answers a different question: what the licensed device does, who manufactures it, which management systems are certified, and what the export certificate establishes.

Class B classification

The operative MD-5 identifies the device as Class B.

The separate issued classification decision is still sought in this collection; the manufacturing licence is the inspected basis for the Class B description.

Inspect the source record

Form MD-5

MFG/MD/2026/000248 · instrument dated 21 April 2026

Names the manufacturer, product, version and non-diagnostic intended use. The FSC cites the base licence date as 20 April; each source is reproduced as printed.

Inspect the source record

ISO 13485:2016

Medical-device quality-management system

Read the certificate’s named entity, scope and dates. Management-system certification is distinct from a child’s clinical outcome.

Inspect the source record

ISO/IEC 27001:2022

Information-security management system

Describes the information-security management system within the certificate’s stated scope. Read the named entity, covered activities and validity dates together.

Inspect the source record

BIS IS 23485:2019

MD/L-2026029599 · 3 September 2026

The schedule names AbilityScore mapping, Prognose, Everyday Therapy through TherapeuticAI, and tracking and correction through Fusion within the certified scope.

Inspect the source record

Free Sale Certificate

FSC/MD/2026/000741 · 23 September 2026

Records Indian domestic marketability and export of the licensed device subject to the importing country’s law.

Inspect the source record

23 SEPTEMBER 2026 · THE EXPORT MILESTONE

Export ready from India.

Section link

Free Sale Certificate FSC/MD/2026/000741 adds a documented export foundation to the licensed PinnacleAI product.

Issued by the State Licensing Authority, TG SAFE, Telangana, on 23 September 2026, the certificate references manufacturing licence MFG/MD/2026/000248. It records that the listed device may be manufactured and sold in India under Indian law and exported as per the law of the importing country.

For potential international partners, the practical value is an inspectable source package: product identity, intended use, manufacturer, licence, management-system scope and the export certificate. Market access then proceeds under each destination’s requirements.

Read the public certificate · Read the forwarding letter

Indian export documentation is established. A foreign registration or marketing authorisation is a separate, country-specific step.

Public redacted Free Sale Certificate, FSC/MD/2026/000741, dated 23 September 2026.
Read the certificate and original-source notes in the FSC evidence record .

RESEARCH THAT READERS CAN INSPECT

Methods, findings and the next questions.

Section link

The research library brings together seven canonical works: six preprints and one report. The records preserve authorship, versions, publication status, original files and reuse licences. Three useful starting points for the PinnacleAI story are:

Preprint · regulatory analysis

The Indian licensing case study

Koti Reddy Saripalli’s documentary analysis of the April 2026 licensing case against later CDSCO guidance. It helps readers follow the regulatory reasoning; it is not an efficacy study.

Read the source guide

DOI 10.5281/zenodo.22761782

Research evidence and regulatory documents answer different questions. The library identifies what is preliminary, what is planned and what has been reported, so a reader can assess each work on its own terms.

Explore all research, books and author profiles · Check the claim-to-source ledger

DOCUMENTED SCALE · 17 JULY 2026

Large numbers, with their definitions attached.

Section link

The dated SRS 4400 factual-findings report records the following distinct measures:

31,052,382
Defined cumulative services
792,614
Beneficiary/family registrations
2.7 billion+
Structured records
49
Centres meeting the report’s operational definition

These figures describe different units at the report date. They provide context for the organisation’s work; they should not be combined into a single child-outcome measure or presented as today’s centre count.

Read the definitions and source pages · Explore scale and mission

INTERNATIONAL LICENSING PATHWAY

Progress that can be verified market by market.

Section link

Pinnacle’s announcement identifies ten target markets. The next chapter is to translate the Indian source package into country-specific requirements, applications and—where issued—registrations.

Organisation-announced target markets · 24 September 2026
MarketCurrent documented stage
New ZealandAnnounced target
United KingdomAnnounced target
BrazilAnnounced target
VietnamAnnounced target
ThailandAnnounced target
ColombiaAnnounced target
PeruAnnounced target
Saudi ArabiaAnnounced target
CanadaAnnounced target
AustraliaAnnounced target

Filing receipts and foreign registrations are not yet verified in this collection. A market advances to “submitted” when a receipt is available and to “registered” when the competent authority’s record is available. The announced MDSAP audit plan remains a plan until scheduling and completion are evidenced; country market access is separate.

Read the dated market-status file

YOUR NEXT STEP

Start with the question that matters to you.

Section link

For parents and families

Discuss your child’s abilities, goals and the support that could help in everyday life. Pinnacle’s National Autism Helpline offers free guidance, 24/7.

Call 9100 181 181

National Autism Helpline

Operated by Pinnacle Blooms Network / Bharath Healthcare Laboratories Private Limited. Free guidance is separate from assessment and therapy fees; normal call charges may apply.

For clinicians and international partners

Begin with the intended use, technical scope and research methods. For an international enquiry, include the country and the product or document you wish to discuss.

Contact the Pinnacle team · Organisation and source contacts

Use the source map below to keep product, research and market-access claims traceable.

QUESTIONS FROM FAMILIES AND PARTNERS

Questions, answered with context.

Section link
What is PinnacleAI®?

PinnacleAI® GPT-OS v1.0.0 is identified in the supplied Indian manufacturing licence as Class B, non-diagnostic developmental-support software for children aged 0–12. Its stated functions include developmental ability measurement, readiness tracking, progress forecasting and adaptive therapy-plan support.

Who is the legal manufacturer?

Bharath Healthcare Laboratories Private Limited is the licence holder and legal manufacturer named in the reviewed regulatory records. Pinnacle Blooms Network is the child-development brand and service ecosystem.

What does the Free Sale Certificate establish?

FSC/MD/2026/000741 records Indian domestic marketability and export eligibility for the licensed device. It supports country-specific market-access applications; it is not approval or registration in another country.

Does PinnacleAI® diagnose children?

No. The licensed product is described as non-diagnostic developmental-support software. Clinical and care decisions remain within the appropriate human and professional review process.

Has PinnacleAI® been registered in other countries?

This page does not claim a foreign registration. Each market will be labelled researching, representative appointed, technical file prepared, submitted, under review or registered only when the corresponding evidence is available.

How can the evidence be reused?

Use the citation downloads and machine-readable JSON or text exports. Cite the exact licence, certificate or dated report for a specific claim and retain its date and scope.

What does “operating system” mean in the PinnacleAI story?

Pinnacle uses GPT-OS in its product name and describes an approach spanning measurement, planning, everyday practice and review. The regulatory description is non-diagnostic developmental-support software; “operating system” is not a separate regulatory approval category.

What does the export milestone mean for my child?

The Free Sale Certificate documents the device’s regulatory standing in India and supports international market-access work. For your child, the useful questions remain the individual goals, the care team, everyday practice, progress review and the relevant centre’s records.

Where can a family start?

Call Pinnacle’s National Autism Helpline on 9100 181 181 for free guidance, available 24/7. The service is operated by Pinnacle Blooms Network / Bharath Healthcare Laboratories Private Limited. Free guidance is separate from assessment or therapy charges; normal call charges may apply.

CLAIM TO ORIGINAL SOURCE

A source for every material claim.

Section link

Use this map when writing about PinnacleAI. Preserve the date, named entity, intended use and source scope.

PinnacleAI story source map · 24 September 2026
ClaimSource and scope
Class B, non-diagnostic developmental-support software; version 1.0.0; children aged 0–12Issued manufacturing licence and annexure; intended use, not diagnostic or outcome authority.
Open the supporting record
Developmental ability measurement, readiness tracking, progress forecasting and adaptive therapy-plan supportLicensed intended functions; human and professional review remains part of care.
Open the supporting record
Bharath Healthcare Laboratories Private Limited is the licence holder and manufacturerLegal entity differs from the Pinnacle Blooms Network brand.
Open the supporting record
BIS licence MD/L-2026029599 dated 3 September 2026Read the management-system scope schedule and dates.
Open the supporting record
FSC/MD/2026/000741 issued 23 September 2026Domestic marketability and export subject to importing-country law; not foreign registration.
Open the supporting record
31,052,382 defined cumulative services; 792,614 beneficiary/family registrations; >2.7 billion structured records; 49 operationally defined centresSRS 4400 factual-findings report dated 17 July 2026; distinct units and definitions, not an outcome denominator.
Open the supporting record
Research preprints, a study protocol and their source files are publicly inspectableRepository publication does not imply peer review, efficacy or regulator endorsement.
Open the supporting record
Ten international markets are announced targetsOrganisation announcement of 24 September 2026; filings and registrations not verified in this collection.
Open the supporting record

Download the source map · CSV · Structured story · JSON · Complete story · plain text

Cite this story

Section link

Bharath Healthcare Laboratories Private Limited. (2026, September 24). PinnacleAI®: the complete story—purpose, research and export readiness. Pinnacle Verify. https://www.pinnacleblooms.org/verify/evidence/pinnacleai-regulatory-journey.html

This is a first-party, source-linked narrative. For a regulatory or research finding, cite the linked original record and its scope. This editorial expansion does not carry a new independent clinical review.

Text · BibTeX · RIS · CSL-JSON · Narrative evidence record · Full citation library

Pinnacle Blooms Network is a brand of Bharath Healthcare Laboratories Private Limited. View legal identity evidence.

Copy this evidence link

Select and copy the link below.